You searched for metabolic diseases - Page 7 of 64

Top biotech grants and campaigns

…the Treatment of Inflammatory Diseases Campaigns closed in Q3 2024 Seeking Novel Solutions to Treat Rare Genetic Skeletal Muscle Diseases Accessible and Transformational Therapeutic Approaches for Hereditary Haemorrhagic Telangiectasia (HHT)…

June 20, 2024 - 2 minutesmins - By Aurore Michelin

khondrion netherlands melas syndrome inherited diseases

Startup Scout 20 Sep 2019

This Biotech Targets Mitochondria to Treat Inherited Diseases

…symptoms. The disease is progressive and eventually fatal. “[Mitochondrial diseases] are complex rare diseases, often overlooked or misdiagnosed because of the wide range and varying severity of symptoms,” Jan Smeitink,…

September 20, 2019 - 3 minutesmins - By Jonathan Smith

In Depth 21 May 2025

Gene therapy for skin diseases: A field still finding its footing

Gene therapy has been a very prolific technology across multiple indications, but what about skin diseases? Some conditions, like psoriasis, affect millions worldwide and can lead to chronic discomfort and…

May 21, 2025 - 7 minutesmins - By Jules Adam

Best in Biotech 28 Feb 2025

Rare Disease Day: seven drugs awaiting approval in 2025

…the past. Rare diseases: how can R&D be improved? As mentioned previously, developing drugs for rare diseases has its own hurdles. According to Neil Ward, vice president of Europe, the…

February 28, 2025 - 10 minutesmins - By Roohi Mariam Peter

8 life science innovators you must meet at BioTrinity 2023

…BioTrinity in London. Each of the 8 companies possesses break-through technologies across a range of fields. Their research spans neurological diseases, oncology, obesity, metabolic diseases, cell therapy, cancer biomarkers, diagnostics…

April 20, 2023 - 4 minutesmins - By External Contributor

Best in Biotech 30 Aug 2023

Five North Carolina biotech companies making their mark

…the nervous system, such as trigeminal neuralgia and epilepsy, and its metabolic pipeline addresses endocrine diseases of impaired glucose metabolism, including diabetes and glycogen storage diseases. In one of the…

August 30, 2023 - 5 minutesmins - By Willow Shah-Neville

Best in Biotech 19 Mar 2024

The 9 hottest private biotech companies in San Diego

…clinical candidates in its pipeline targeting rare kidney and metabolic diseases. The most recent update from its pipeline came in December 2023, when the company announced it had initiated a…

March 19, 2024 - 11 minutesmins - By Willow Shah-Neville

News and Trends 10 Sep 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

…cells function, and ultimately, diseases. So, targeting these lncRNAs can help combat these diseases. “There is work out there showing that they can work in oncology, neuroscience, cardiometabolism, and inflammation….

September 10, 2024 - 5 minutesmins - By Roohi Mariam Peter

News and Trends 6 Feb 2025

Top biotech deals of January 2025

…Variant Bio to identify new targets for metabolic diseases with the help of Variant’s drug discovery platform. Variant can reap up to $50 million in upfront and milestone payments. Finally,…

February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 15 Jun 2017

Where to Find the Perfect Mix of International and German Biotechs? Berlin!

…as oncology, neuroscience, cardiovascular and metabolic diseases, and immunology. Research partners can also focus on the study of rare diseases or vaccines. Dr Peter Löschmann, director of the BRL, explains…

June 15, 2017 - 6 minutesmins - By External Contributor

In Depth 9 May 2022

Exosome Therapy: Borrowing from Nature’s Toolbox

…picked some of the rare metabolic diseases, such as urea cycle disorders and those that have no curative therapy and where the standard of care is extremely suboptimal. In all…

May 9, 2022 - 11 minutesmins - By Farhan Mitha

Best in Biotech 14 May 2024

Six biotechs in Belgium making leaps in the clinic

…of autoimmune diseases, Imcyse develops immunotherapies based on synthetic peptides called imotopes. These peptides can block immune responses that trigger immune-mediated diseases, including type 1 diabetes, multiple sclerosis, and rheumatoid…

May 14, 2024 - 8 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Top biotech grants and campaigns

This Biotech Targets Mitochondria to Treat Inherited Diseases

Gene therapy for skin diseases: A field still finding its footing

Rare Disease Day: seven drugs awaiting approval in 2025

8 life science innovators you must meet at BioTrinity 2023

Five North Carolina biotech companies making their mark

The 9 hottest private biotech companies in San Diego

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Top biotech deals of January 2025

Where to Find the Perfect Mix of International and German Biotechs? Berlin!

Exosome Therapy: Borrowing from Nature’s Toolbox

Six biotechs in Belgium making leaps in the clinic

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!